Sanofi become the UK’s first ‘Skin Cancer SOS’ Accredited Partner of specialist awareness charity Skcin

Innovative, global healthcare company Sanofi are officially the UK’s first employer to become a Skin Cancer SOS Accredited Partner - with the roll out of a workplace-sponsored, disease prevention and health promotion programme, dedicated to the prevention and early detection of skin cancer.

 

 

 

 

 

 

 

 

 

 

 

 

Supporting a call to action from the UK’s leading skin cancer awareness charity Skcin, for businesses and organisations to help tackle a major public health concern, Sanofi are implementing a series of initiatives developed by the charity to promote skin health and surveillance among their employee community.

 

Employees will be educated on the prevalence, causes and risk factors relating to skin cancer in addition to ways in which they can reduce their risk and check their skin for the early warning signs. To further support employees, Sanofi are also rolling out the first white label version of the Skcin App.

 

Developed by Skcin, the app provides employees with comprehensive, educational and self-management tools to empower and support them in taking charge of their skin health, helping them to reduce their risk of skin cancer and promote early detection, diagnosis and treatment.

 

“We’re delighted to become the UK’s first Skin Cancer SOS Accredited workplace, in partnership with Skcin. Skin cancer is the most common form of cancer in the UK and rates continue to rise, so there’s a real need to help educate people on prevention and early detection,” said Jessamy Baird, Managing Director, Sanofi UK & Ireland. “The health and wellbeing of our employees is of paramount importance to us and we’re proud to offer the Skcin App to help them look after their skin health.”

 

Marie Tudor, CEO of Skcin said: “We are delighted to welcome onboard Sanofi as our first UK accredited partner. Modifiable health risks that lead to disease can be significantly decreased through workplace-sponsored, health promotion and disease prevention programmes. As such, our Skin Cancer SOS Accreditation Programme aims to support and recognise the valuable contribution businesses and organisations, both large and small can make in helping to combat the soaring rates of skin cancer - locally, nationally and globally”.

 

 

—————————————————————————————————————————————

 

 

Skin cancer statistics in the UK.

 

• 1 in every 3 cancers diagnosed is skin cancer - it is the most common cancer in the UK and worldwide.

• 1 in 4 males and 1 in 5 females will be diagnosed with non-melanoma skin cancer.

• Over 210,000 cases of non-melanoma skin cancers are diagnosed annually, with cases expected to reach 400,000 annually by 2025.

• Over 16,000 cases of melanoma (the deadliest form of skin cancer) are diagnosed annually and the incidence in Britain has risen faster than any other common cancer.

• 1 in 36 males and 1 in 47 females will be diagnosed with melanoma (the deadliest form of skin cancer) and it is now one of the biggest killing cancers in young adults (aged 15-34).

 

 

Skcin; The Karen Clifford Skin Cancer Charity:

 

Skcin are the UK’s leading skin cancer awareness charity, dedicated to the prevention and early detection of skin cancer through educational intervention for public benefit. Skcin’s mission is to combat statistics head on and save lives by preventing skin cancer for future generations, improving patient outcomes through early diagnosis and relieving the significant burden of skin cancer on the NHS.

 

For further information contact: marie.tudor@skcin.org